Insider trades
OrbiMed Capital GP VII, Director of ADARx Pharmaceuticals ADRX, has filed 31 purchases and 77 sales on the open market. Over the past 12 months that comes to a net sale of $533K. The latest trade was on 09/28.
OrbiMed Capital GP VII
Director
- Company
- ADARx Pharmaceuticals ADRX
- First filing
- 23/02/23
- Trades
- 165 trades
- Buys / sales
- 31 / 77
- 12-month net buying
- −$533K
- Last trade
- 09/28
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ADRX | Open-market buy | 09/28 | 09/30 | 950,000 sh3 trades | $17.00avg. | $16,150,000 | No record |
ETRA | Open-market buy | 09/21 | 09/23 | 1,333,333 sh2 trades | $15.00avg. | $19,999,995 | +313.8% |
ELVN | Open-market sale | 06/22 | 06/24 | 860,123 sh4 trades | $45.36avg. | $39,014,045.6 | −11.6% |
ELVN | Open-market sale | 06/15 | 06/17 | 281,408 sh2 trades | $45.02avg. | $12,668,988.16 | −3.7% |
QTTB | Open-market buy | 05/28 | 06/01 | 1,875,000 sh2 trades | $8.00avg. | $15,000,000 | No record |
PASG | Open-market sale | 25/06/24–25/06/26 | 25/06/26 | 583,657 sh3 trades | $0.34avg. | $197,238.81 | −8.8% |
PASG | Open-market sale | 25/04/22–25/04/24 | 25/04/24 | 235,572 sh3 trades | $0.33avg. | $78,730.58 | −3.4% |
PASG | Open-market sale | 25/04/15–25/04/17 | 25/04/17 | 149,054 sh3 trades | $0.33avg. | $49,704.12 | −2.1% |
MBX | Open-market buy | 25/02/14–25/02/18 | 25/02/19 | 190,672 sh4 trades | $10.60avg. | $2,020,755.6 | +34.2% |
PASG | Open-market sale | 25/01/10–25/01/14 | 25/01/14 | 223,219 sh3 trades | $0.64avg. | $142,223.38 | −3.1% |
PASG | Open-market sale | 25/01/06–25/01/08 | 25/01/08 | 147,024 sh3 trades | $0.70avg. | $103,305.69 | −2.0% |
Passage BIOPASG | Open-market sale | 24/12/20 | 24/12/26 | 230,321 sh | $0.60 | $138,192.6 | −3.0% |
PASG | Open-market sale | 24/12/09–24/12/11 | 24/12/11 | 62,276 sh3 trades | $0.83avg. | $51,988.04 | −0.8% |
PASG | Open-market sale | 24/12/04–24/12/06 | 24/12/06 | 97,103 sh2 trades | $0.80avg. | $77,338.46 | −1.2% |
Passage BIOPASG | Open-market sale | 24/09/19 | 24/09/23 | 39,300 sh | $0.71 | $27,903 | −0.5% |
PASG | Open-market sale | 24/09/16–24/09/18 | 24/09/18 | 200,131 sh3 trades | $0.73avg. | $146,726.63 | −2.5% |
MBX | Open-market buy | 24/09/16 | 24/09/17 | 750,000 sh2 trades | $16.00avg. | $12,000,000 | No record |
KROS | Open-market sale | 24/08/13 | 24/08/15 | 250,000 sh2 trades | $44.01avg. | $11,002,500 | −67.7% |
| Open-market sale10b5-1 plan | 24/07/15–24/07/16 | 24/07/17 | 56,164 sh6 trades | $10.00avg. | $561,640 | −6.9% | |
ELVN | Open-market sale | 24/05/16 | 24/05/20 | 1,033,300 sh2 trades | $22.14avg. | $22,877,262 | −11.9% |
